Seres Therapeutics, Inc. (MCRB) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2012: -$4.35M2013: -$11.12M2014: -$26.72M2015: $205.39M2016: $132.63M2017: $60.70M2018: -$48.05M2019: -$48.32M2020: $174.75M2021: $131.51M2022: $10.78M2023: -$44.86M2024: $13.78M2025: $44.22M$44.22M
2012Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$44.22M+220.8%
2024$13.78M+130.7%
2023-$44.86M-516.0%
2022$10.78M-91.8%
2021$131.51M-24.7%
2020$174.75M+461.6%
2019-$48.32M-0.6%
2018-$48.05M-179.2%
2017$60.70M-54.2%
2016$132.63M-35.4%
2015$205.39M+868.7%
2014-$26.72M-140.4%
2013-$11.12M-155.7%
2012-$4.35M